Industry reports
Editor highlights

General Medicine and Specialty Medicine Industry Market Research Reports in China, April 2014

You might be interested in: dentistry, oncology, pediatric, more »

» View Public Reports

1-30 of 44 reports

Company Report: General Medicine and Specialty Medicine in China for Year 2014

  • Company report
  • February 2014
  • 25 pages
  • Industries: General Medicine and Specialty Medicine
  • Countries: China

Company Report: General Medicine and Specialty Medicine in China for Year 2013

  • Company report
  • October 2013
  • 3 pages
  • Industries: General Medicine and Specialty Medicine
  • Countries: China

Company Report: Rheumatology in China and The United Kingdom for Year 2013

  • Company report
  • October 2013
  • 7 pages

... And solutions in partnership with rheumatology loose and bound inserts available belly band/cover tip sponsored supplements article reprints and eprints useful as conference handouts rheumatology volume 52 ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: China, United Kingdom

General Medicine and Specialty Medicine Business Analysis in The United States and Asia

  • Industry report
  • June 2013
  • 64 pages

... Mackenzie ej, ephraim pl, travison tg, brookmeyer r. Estimating the prevalence of limb loss in the united states: 2005 to 2050. Archives of physical medicine and rehabilitation2008 ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: China, United States, Asia

Investor presentation: General Medicine and Specialty Medicine in China for Year 2013

  • Company report
  • March 2013
  • 36 pages

... Bi 1034020 na na na na rsv 5 0 % c o c o na na various various various various fully partnered na oncology/neurology immunology potential to evolve into at least 4 co ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: China

Investor presentation: General Medicine and Specialty Medicine in China for Year 2013

  • Company report
  • March 2013
  • 36 pages

... Na na na na rsv 50 % co co na na various various various various fully partnered na oncology/neurology immunology potential to evolve into at least 4 co-co programmes bone ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: China

The Chinese General Medicine and Specialty Medicine Industry Brief

  • Industry report
  • January 2013
  • 6 pages

... With specialist training rooms, including diagnostics, check- up, technical, cpr, icu simulator, or simulator, paediatrics, nursing, surgery and mini-invasive surgery, an osce station and a general practice office ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: China

Company Report: Regenerative Medicine in The United States, Europe and China for Year 2012

  • Company report
  • December 2012
  • 3 pages

... Burns, plastic surgery and dermatology conferences. Avita will continue to participate in these conferences, display its products and sponsor presentations on clinical results achieved with recell by high ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: United States, Europe, China

Company Report: General Medicine and Specialty Medicine in China for Year 2012

  • Company report
  • November 2012
  • 2 pages
  • Industries: General Medicine and Specialty Medicine
  • Countries: China

General Medicine and Specialty Medicine Sector in China

  • Industry report
  • September 2012
  • 2 pages
  • by Corporation

... Cardiology product, as well as several of its oncology products exclusively promoted in china for pfizer and baxter were reduced at or below the average price reduction announced by the government ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: China

Bloomage BioTechnology Corporation Ltd. - Company Report for Year 2012

  • Company report
  • July 2012
  • 2 pages
  • by Corporation
  • Industries: General Medicine and Specialty Medicine
  • Countries: China

Company Report: General Medicine and Specialty Medicine in China for Year 2012

  • Company report
  • June 2012
  • 9 pages
  • by Market Research Publisher

... Oxygenators, also named as artificial lung, are for the use in extra-corporal on-pump cardiac surgery, with the function of oxygenating the non-oxygenated blood into oxygenated blood. According ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: China

Company Report: Eye Care in India, China and Japan for Year 2012

  • Company report
  • June 2012
  • 2 pages

... eye care * as of june 27, 2012, we have changed our organizational structure to three in-house companies. As a result, the former eye care business unit became the eye care company. The vision ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: India, China, Japan

SciClone Pharmaceuticals Inc. - Company Report for Year 2012

  • Company report
  • May 2012
  • 2 pages
  • by Corporation

... Business in china and a product portfolio of therapies for oncology, infectious diseases and cardiovascular, urological, respiratory, and central nervous system disorders. Sciclone's zadaxin (thymalfasin ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: China, United States

Walden Group - Company Report for Year 2012

  • Company report
  • March 2012
  • 17 pages
  • Industries: General Medicine and Specialty Medicine
  • Countries: United States, China

Company Report: General Medicine and Specialty Medicine in Singapore, China and Japan for Year 2012

  • Company report
  • March 2012
  • 11 pages

... cardiology products (ivp) and critical care products (ccp). The ivp business is driven by the sales of its des products using technology developed in house. The company also collects royalty and licensing ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: Singapore, China, Japan

Investor presentation: Interventional Cardiology in China for Year 2012

  • Company report
  • March 2012
  • 23 pages

... Revenue contribution for biosensors comes mainly from the interventional cardiology segment interventional cardiology grew 56% from fy 11 interventional cardiology revenue grew 56% from fy11, driven ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: China

Company Report: Dentistry in China and Singapore for Year 2012

  • Company report
  • March 2012
  • 3 pages
  • Industries: General Medicine and Specialty Medicine
  • Countries: China, Singapore

Company Report: General Medicine and Specialty Medicine in China for Year 2012

  • Company report
  • March 2012
  • 6 pages
  • by Corporation
  • Industries: General Medicine and Specialty Medicine
  • Countries: China

The Chinese Surgery Industry Brief

  • Industry report
  • January 2012
  • 48 pages

... Was approximately 950,000 eyes (usd $713 million) per year, a level that has overtaken the united states (u.S.) As the largest global laser refractive surgery market in terms of procedure volume ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: China

Company Report: General Medicine and Specialty Medicine in China for Year 2011

  • Company report
  • December 2011
  • 4 pages

... Will be payable if the insured, after a hospital confinement whereby a daily hospital income benefit is payable, dies as a result (directly and independently of all other causes) of the negligence of a medical ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: China

Company Report: General Medicine and Specialty Medicine in China for Year 2011

  • Company report
  • December 2011
  • 8 pages
  • by Corporation

... Is a revenue-generating, profitable, specialty pharmaceutical company with a substantial commercial business in china and a product portfolio of therapies for oncology, infectious diseases and cardiovascular ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: China

Company Report: General Medicine and Specialty Medicine in China for Year 2011

  • Company report
  • December 2011
  • 22 pages
  • by Market Research Publisher
  • Industries: General Medicine and Specialty Medicine
  • Countries: China

SciClone Pharmaceuticals Inc. - Company Report for Year 2011

  • Company report
  • December 2011
  • 2 pages
  • by Corporation

... About sciclone sciclone pharmaceuticals is a us-based, china-focused specialty pharmaceutical company with a product portfolio of therapies for oncology, infectious diseases and cardiovascular ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: China, United States

Professional Medical - Annual Report 2011

  • Company report
  • November 2011
  • 90 pages

... From 31.2% To 23.5% As compared to the prior comparative period. Cost of revenue for cosmetic surgery services decreased by $0.1 Million or 28.3% From $0.5 Million to $0.3 Million. Cost of revenue ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: China

General Medicine and Specialty Medicine Sector in China

  • Industry report
  • October 2011
  • 23 pages

... Isotretinoin: epidemiological studies to quantify in-utero isotretinoin pregnancy exposure rate, birth defect rate and to assess risk factors of birth defects following in-utero isotretinoin exposures ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: China

Company Report: General Medicine and Specialty Medicine in China for Year 2011

  • Company report
  • August 2011
  • 7 pages

... S ministry of health had released a guideline in august 2011 and made it clear that the cardiovascular interventional surgeries will not only be conducted by third level hospitals, and more second level ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: China

Company Report: General Medicine and Specialty Medicine in China for Year 2011

  • Company report
  • August 2011
  • 49 pages

... On may 30, 2005 as a limited liability company. Sichuan shesays is a clinic for providing professional medical beauty services, cosmetic surgery services and cosmetic dentistry services to customers in prc ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: China

Company Report: Dentistry in China and Singapore for Year 2011

  • Company report
  • March 2011
  • 5 pages

... As the results were largely in-line with our expectation. We expect to see higher profitability in 4q fy12 due to higher seasonal demand for dental services. Maintain increase exposure with an intrinsic value ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: China, Singapore

SciClone Pharmaceuticals Inc. - Investment Analysis, March 2011

  • Company report
  • March 2011
  • 7 pages
  • by Corporation

... August 8, 2012 sciclone reports financial results for the second quarter 2012 continued strong revenue growth for zadaxin(r), as well as primary care and oncology product lines foster city, ca ...

  • Industries: General Medicine and Specialty Medicine
  • Countries: China

» Purchase Premium Reports (From $ 175 - $ 4 450)

45 reports
MediPoint: Sports Medicine - APAC Analysis and Market Forecasts

MediPoint: Sports Medicine - APAC Analysis and Market Forecasts

  • $ 4 450
  • Industry report
  • March 2014
  • by Global Data

MediPoint: Sports Medicine - APAC Analysis and Market Forecasts Summary This report focuses on the sports medicine market, which includes implants and arthroscopic capital equipment. The orthopedic sports ...

Eye Care In China

April 2013 $ 898

Plastic Surgery Hospitals In China

October 2012 $ 1 020

ReportLinker is a professional search engine that provides an easy access to 1,2 million market research reports and industry statistics published by 200,000 authoritative sources.